Humanized TNF-Alpha Mouse Model for In Vivo Preclinical Studies
Applications: inflammation and autoimmune disease
The humanized TNF-α mouse model allows in vivo efficacy and safety assessment of anti-human TNF-α compounds in the field of autoimmune diseases and inflammation.
Model features:
- Humanization by gene substitution; the murine TNF-α gene is inactivated and replaced by the human TNF-α genomic portion
- Human TNF-α expression is driven by the mouse TNF-α endogenous promoter (physiological TNF-α regulation and expression pattern)
- Physiological expression level of human TNF-α (Fig. 1B)
- No expression of murine TNF-α (Fig. 1A)
- No physiological deregulation reported
Model validation
Fig. 1) Mean plasmatic concentrations of murine TNF-α and human TNF-α following LPS injection |
Mean concentrations of murine TNF-α (A) and human TNF-α (B) measured by ELISA from plasma samples collected from WT (n=2) and KI (n=2) mice treated with saline solution vs. LPS. |
Ready to be shipped to your lab
- Available onto C57BL/6J genetic background
- Health-certified prior to delivery: SOPF (Specific and Opportunistic Pathogen-Free)
- Worldwide delivery using logistic networks of renowned professional breeders
Access conditions
- Freedom to operate for basic and pharmaceutical research
- Generated data are the exclusive property of the customer and royalty-free
- The model is available through in-licensing (flat annual fee, depending on company size)
- On-demand production of cohorts by contract breeding